American Association for Cancer Research

Table 2.

NAT2 allele frequencies in colorectal cancer patients (CRC⁺) and unaffected MMR gene mutation carriers (CRC⁻)

Cancer status	n	NAT2*4	NAT2*5A	NAT2*6B	NAT2*7A
CRC⁺	117	0.72	0.20	0.07	0.01
CRC⁻	94	0.73	0.21	0.06	0

Cancer status	n	NAT2*4	NAT2*5A	NAT2*6B	NAT2*7A
CRC⁺	117	0.72	0.20	0.07	0.01
CRC⁻	94	0.73	0.21	0.06	0